Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, vol.165, issue.6, pp.1548-50, 2016. ,
Moving towards a molecular taxonomy of autoimmune rheumatic diseases, Nat Rev Rheumatol, vol.14, issue.2, pp.75-93, 2018. ,
The type I interferon system in the development of lupus, Semin Immunol, vol.23, issue.2, pp.113-134, 2011. ,
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway, Ann Rheum Dis, vol.70, issue.11, pp.2029-2065, 2011. ,
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression, Ann Rheum Dis, vol.72, issue.5, pp.728-763, 2013. ,
Evolutionary genetic dissection of human interferons, J Exp Med, vol.208, issue.13, pp.2747-59, 2011. ,
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling, Nat Genet, vol.46, issue.5, pp.503-512, 2014. ,
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies, Arthritis Rheum, vol.54, issue.6, pp.1906-1922, 2006. ,
Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J Exp Med, vol.214, issue.5, pp.1547-55, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01534181
Monitoring disease activity in systemic lupus erythematosus with singlemolecule array digital ELISA quantification of serum interferon-alpha, Arthritis Rheumatol, vol.71, issue.5, pp.756-765, 2019. ,
Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, Lancet Neurol, vol.12, issue.12, pp.1159-69, 2013. ,
AIREdeficient patients harbor unique high-affinity disease-ameliorating autoantibodies, Cell, vol.166, issue.3, pp.582-95, 2016. ,
Interferome v2.0: an updated database of annotated interferon-regulated genes, Nucleic Acids Res, vol.41, pp.1040-1046, 2013. ,
Development and validation of an ultrasensitive single molecule array digital enzyme-linked immunosorbent assay for human interferon-alpha, J Vis Exp, vol.136, 2018. ,
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, vol.40, issue.9, p.1725, 1997. ,
The probable role of interferon in allergy, Ann Allergy, vol.35, issue.6, pp.356-60, 1975. ,
The interferon signature in autoimmune diseases, Curr Opin Rheumatol, vol.25, issue.2, pp.248-53, 2013. ,
Assessment of type I interferon signaling in pediatric inflammatory disease, J Clin Immunol, vol.37, issue.2, pp.123-155, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01908851
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features, Sci Rep, vol.8, issue.1, p.5793, 2018. ,
Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus, Arthritis Rheum, vol.63, issue.4, pp.1044-53, 2011. ,
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease, Arthritis Rheum, vol.52, issue.5, pp.1491-503, 2005. ,
IFNalpha and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus, Ann Rheum Dis, vol.72, issue.10, pp.1639-1684, 2013. ,
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE, Lupus Sci Med, vol.2, issue.1, p.80, 2015. ,
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus, Ann Rheum Dis, vol.68, issue.9, pp.1440-1446, 2009. ,
Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus, BMC Med Genet, vol.12, issue.1, p.4, 2019. ,
Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis, Arthritis Res Ther, vol.19, issue.1, p.41, 2017. ,
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status, Ann Rheum Dis, vol.77, pp.1432-1441, 2018. ,
Involvement of interferon in virusinduced lymphopenia, Cell Immunol, vol.79, issue.1, pp.11-25, 1983. ,
Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens, Gut, vol.54, issue.7, pp.1014-1034, 2005. ,
Aicardi-Goutieres syndrome and the type I interferonopathies, Nat Rev Immunol, vol.15, issue.7, pp.429-469, 2015. ,
Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey, J Clin Immunol, vol.36, issue.3, pp.220-254, 2016. ,
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients, Neurol Sci, vol.36, issue.12, pp.2263-2271, 2015. ,
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia, Blood, vol.108, issue.10, pp.3253-61, 2006. ,
Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen-and Sjogren's syndrome autoantigen-associated RNA, Arthritis Rheum, vol.54, issue.6, pp.1917-1944, 2006. ,
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNApeptide complexes in systemic lupus erythematosus, Sci Transl Med, vol.3, issue.73, pp.73-92, 2011. ,
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation, J Clin Immunol, vol.33, issue.5, pp.954-64, 2013. ,
Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome, Ann Rheum Dis, vol.76, issue.4, pp.721-751, 2017. ,
Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA-and RNA-sensing receptors?, Arthritis Res Ther, vol.20, issue.1, p.4, 2018. ,
Innate immune stimuli modulate bone marrowderived dendritic cell production in vitro by toll-like receptor-dependent and -independent mechanisms, Immunology, vol.131, issue.4, pp.513-537, 2010. ,